Life-science sector research firm EvaluatePharma has analyzed worldwide sales figures and trends for leading pharmaceutical companies and projects that by 2018, Novartis (NYSE:NVS) will become the world’s largest prescription drug manufacturer.
By then, only one American drugmaker, Pfizer (NYSE:PFE), will remain in the top 5, according to EvaluatePharma.
Here are the firm’s Top 15 Pharmaceutical manufactures in 2018:
- Sanofi (NYSE:SNY)
- GlaxoSmithKline (NYSE:GSK)
- Roche (PINK:RHHBY)
- Merck & Co. (NYSE:MRK)
- Johnson & Johnson (NYSE:JNJ)
- Teva (NASDAQ:TEVA)
- AstraZeneca (NYSE:AZN)
- Abbott Laboratories (NYSE:ABT)
- Bristol-Myers Squibb (NYSE:BMY)
- Nordisk (NYSE:NVO)
- Takeda (PINK:TKPYY)
- Bayer (PINK:BAYRY)
- Gilead Sciences (NASDAQ:GILD)
For EvaluatePharma’s complete list and data, click here.